[Ip-health] KEI requests that federal government use compulsory licenses on Kaleo held patents for devices used to administer opioid overdose reversal drug

Kim Treanor kim.treanor at keionline.org
Mon Apr 2 07:12:06 PDT 2018


https://www.keionline.org/27541

KEI requests that federal government use compulsory licenses on Kaléo held
patents for devices used to administer opioid overdose reversal drug

KEI has submitted a request to Mr. James Carroll, Acting Director of the
Office of National Drug Control Policy, and to Ms. Kellyanne Conway,
Counselor to the President and appointed “opioid czar,” asking that the
federal government use its authority under 28 U.S.C. § 1498(a), to
authorize third parties to use patents held by kaléo Inc., in order to
expand competition and lower prices for devices that are used to deliver
naloxone to reverse an opioid overdose.

In a case similar to the Epipen, the drug, in this case, naloxone, is
available as a generic, but an important device used to deliver the
treatment is protected by several patents. Specifically, the letter to
Carroll and Conway addresses a device sold under the brand name of Evzio by
the company now known as kaléo Inc.. Kaléo lists 25 patents for Evzio in
the FDA Orange Book. All 25 patents list two Virginia based twin brothers,
Eric and Evan Edwards, among the inventors.

Evzio, the only auto-injector for naloxone, has increased in price over
500% since it was first entered on to the market, and a two pack now costs
$4,500.[1}

-- 
Kim Treanor
Knowledge Ecology International
kim.treanor at keionline.org
tel.: +1.202.332.2670 <(202)%20332-2670>


More information about the Ip-health mailing list